Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apellis Pharmaceuticals (APLS) Inventory Average (2021 - 2025)

Apellis Pharmaceuticals (APLS) has 5 years of Inventory Average data on record, last reported at $132.7 million in Q4 2025.

  • For Q4 2025, Inventory Average rose 31.07% year-over-year to $132.7 million; the TTM value through Dec 2025 reached $132.7 million, up 31.07%, while the annual FY2025 figure was $112.0 million, 1.67% down from the prior year.
  • Inventory Average reached $132.7 million in Q4 2025 per APLS's latest filing, up from $121.9 million in the prior quarter.
  • Across five years, Inventory Average topped out at $157.0 million in Q2 2024 and bottomed at $2.7 million in Q3 2021.
  • Average Inventory Average over 5 years is $88.6 million, with a median of $97.6 million recorded in 2023.
  • Peak YoY movement for Inventory Average: surged 1900.81% in 2022, then plummeted 46.73% in 2025.
  • A 5-year view of Inventory Average shows it stood at $9.0 million in 2021, then skyrocketed by 709.81% to $72.7 million in 2022, then surged by 68.36% to $122.5 million in 2023, then dropped by 17.33% to $101.2 million in 2024, then soared by 31.07% to $132.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $132.7 million in Q4 2025, $121.9 million in Q3 2025, and $101.7 million in Q2 2025.